How have INCR shares performed in 2024?

InterCure's stock was trading at $1.2898 at the beginning of the year. Since then, INCR shares have increased by 96.2% and is now trading at $2.53. View the best growth stocks for 2024 here .

Are investors shorting InterCure?

InterCure saw a drop in short interest in March. As of March 31st, there was short interest totaling 90,200 shares, a drop of 14.6% from the March 15th total of 105,600 shares. Based on an average trading volume of 90,900 shares, the days-to-cover ratio is currently 1.0 days. Approximately 0.3% of the company's stock are sold short. View InterCure's Short Interest .

When is InterCure's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Monday, May 20th 2024. View our INCR earnings forecast .

How do I buy shares of InterCure?

Shares of INCR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

NASDAQ:INCR

InterCure (INCR) Stock Price, News & Analysis

→ Tiny Biotech Stock Wins $75 Billion Patent (From Behind the Markets) (Ad)

Free INCR Stock Alerts

$2.53

-0.06 (-2.32%)

(As of 04/19/2024 ET)

Compare

Today's Range: $2.48
▼
$2.57
50-Day Range: $1.56
▼
$2.72
52-Week Range: $0.99
▼
$2.92

Volume: 9,502 shs
Average Volume: 82,669 shs
Market Capitalization: $115.29 million

P/E Ratio: 19.46
Dividend Yield: N/A
Price Target: N/A

Get InterCure alerts:

Ad Behind the Markets

Tiny Biotech Stock Wins $75 Billion Patent

A little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.

Find out more here >>>

About InterCure Stock (NASDAQ:INCR)

InterCure Ltd., together with its subsidiaries, engages in the research, cultivation, production, and distribution of pharmaceutical-grade cannabis and cannabis-based products for medical use in Israel and internationally. The company offers dried cannabis inflorescences and cannabis extract mixed with oil. It also invests in biomed sector. The company was incorporated in 1994 and is headquartered in Herzliya, Israel.

INCR Stock Price History

30 days | 90 days | 365 days | Advanced Chart

INCR Stock News Headlines

April 14, 2024 | americanbankingnews.com

InterCure Ltd. (NASDAQ:INCR) Short Interest Down 14.6% in March

April 1, 2024 | msn.com

This Israeli Cannabis Operator Anticipates $95.4M In Revenue Despite Gaza Conflict

April 19, 2024 | Gold Safe Exchange (Ad)

The “Perfect Storm” for Gold

Gold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.

March 22, 2024 | businesswire.com

InterCure Congratulates Germany on Cannabis Reform, Expanding its Global Footprint

February 23, 2024 | businesswire.com

PESG Industry Updates: Germany's Cannabis Act and Its Impact on the Medical Cannabis Landscape

February 13, 2024 | finance.yahoo.com

InterCure Provides an Update Regarding Nir Oz Facility

February 13, 2024 | globenewswire.com

InterCure Provides an Update Regarding Nir Oz Facility

January 31, 2024 | msn.com

InterCure to buy Isreal-based Leon cannabis pharmacy chain

April 19, 2024 | Gold Safe Exchange (Ad)

The “Perfect Storm” for Gold

Gold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.

January 18, 2024 | investing.com

Intrakat Technikon Kai Energeiakon Ergon AE (INCr)

January 10, 2024 | msn.com

WKEY, INCR and ZJYL are among pre market gainers

January 9, 2024 | benzinga.com

Intercure Stock (NASDAQ:INCR) Dividends: History, Yield and Dates

January 6, 2024 | investing.com

INCR_t3 Historical Data

November 9, 2023 | morningstar.com

Intercure Ltd INCR

October 17, 2023 | msn.com

InterCure says one of its sites designated as closed military area by Israeli authorities

September 1, 2023 | benzinga.com

Canndoc Reports Record Revenue Amid Cannabis Market Turmoil

August 22, 2023 | theglobeandmail.com

Closing Bell: Intercure Ltd up on Monday (INCR-U)

August 19, 2023 | theglobeandmail.com

ul: Bottom 25 Performing Stocks Year-to-Date on TSX (INCR-U)

August 3, 2023 | msn.com

InterCure: Leader In Israel's Growing Medical Cannabis Market

July 23, 2023 | theglobeandmail.com

Intercure: Top 10 Undervalued Micro Cap Stocks on TSX (INCR-U)

July 10, 2023 | financialpost.com

InterCure Ltd. Announces Proposed Voluntary Delisting from the Toronto Stock Exchange and shall continue to be listed on the NASDAQ and TASE

May 16, 2023 | finanznachrichten.de

InterCure Ltd.: InterCure Announces Record Breaking First Quarter Revenues with 22% growth YOY

May 16, 2023 | msn.com

InterCure Stock Trading Lower On Q1 Revenue Growth Of 22%, Here Are The Details

May 15, 2023 | benzinga.com

InterCure Announces Record Breaking First Quarter Revenues with 22% growth YOY

April 27, 2023 | theglobeandmail.com

Closing Bell: Intercure Ltd down on Monday (INCR-U)

April 26, 2023 | theglobeandmail.com

Closing Bell: Intercure Ltd flat on Monday (INCR-U)

April 25, 2023 | finance.yahoo.com

InterCure Informs That A Lawsuit Was Filed Against the Company by Minority Shareholders of Its Subsidiary

See More Headlines

Receive INCR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for InterCure and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Today: 4/19/2024
Next Earnings (Estimated): 5/20/2024
Fiscal Year End: 12/31/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Sector: Medical
Industry: Pharmaceutical preparations
Sub-Industry: N/A
Current Symbol: NASDAQ:INCR
CUSIP: N/A
CIK: 1857030
Web: www.intercure.co
Phone: 972774605012
Fax: N/A
Employees: 370
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: 19.46
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: N/A
Quick Ratio: N/A

Sales & Book Value

Annual Sales: $115.83 million
Price / Sales: 1.00
Cash Flow: $0.42 per share
Price / Cash Flow: 5.99
Book Value: $3.64 per share
Price / Book: 0.70

Miscellaneous

Outstanding Shares: 45,570,000
Free Float: 45,464,000
Market Cap: $115.29 million
Optionable: Optionable
Beta: 1.73

The Best High-Yield Dividend Stocks for 2024

Looking to generate income with your stock portfolio? Use these ten stocks to generate a safe and reliable source of investment income.

Get This Free Report

Key Executives

Mr. Alexander Rabinovich (Age 53)
CEO & Director
Comp: $500k
Mr. Amos Cohen (Age 45)
Chief Financial Officer
Comp: $848k
Einat Zehavi
Vice President of Sales
Mr. Omri Batzir
Corporate Controller

Key Competitors

View All Competitors

Institutional Ownership

View All Institutional Transactions

INCR Stock Analysis - Frequently Asked Questions

How have INCR shares performed in 2024?: InterCure's stock was trading at $1.2898 at the beginning of the year. Since then, INCR shares have increased by 96.2% and is now trading at $2.53.
View the best growth stocks for 2024 here.
Are investors shorting InterCure?: InterCure saw a drop in short interest in March. As of March 31st, there was short interest totaling 90,200 shares, a drop of 14.6% from the March 15th total of 105,600 shares. Based on an average trading volume of 90,900 shares, the days-to-cover ratio is currently 1.0 days. Approximately 0.3% of the company's stock are sold short.
View InterCure's Short Interest.
When is InterCure's next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Monday, May 20th 2024.
View our INCR earnings forecast.
How do I buy shares of InterCure?: Shares of INCR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:INCR) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial